Vir Biotechnology (VIR) Gross Profit (2020 - 2025)

Vir Biotechnology (VIR) has 6 years of Gross Profit data on file, last reported at $1.2 million in Q2 2025.

• For the quarter ending Q2 2025, Gross Profit fell 60.21% year-over-year to $1.2 million; the trailing twelve-month figure through Jun 2025 stood at $18.3 million (down 75.08% YoY), and the FY2025 full-year result was $68.5 million, down 6.58% from the prior year.
• Gross Profit eased to $1.2 million in Q2 2025, from $3.0 million in the prior quarter.
• In the past five years, Gross Profit ranged from a high of $1.1 billion in Q1 2022 to a low of $1.2 million in Q2 2025.
• A 5-year average of $151.5 million and a median of $14.3 million in 2022 frame the typical range for Gross Profit.
• Across the five-year window, Gross Profit surged 57709.21% in 2022 and tumbled 99.26% in 2023, its largest moves.
• Tracing VIR's Gross Profit over 5 years: stood at $755.9 million in 2021, then slumped by 94.26% to $43.4 million in 2022, then sank by 63.17% to $16.0 million in 2023, then retreated by 26.89% to $11.7 million in 2024, then slumped by 89.71% to $1.2 million in 2025.
• Business Quant data shows VIR's Gross Profit at $1.2 million in Q2 2025, $3.0 million in Q1 2025, and $11.7 million in Q4 2024.